Movember is investing up to £300,000 per grant as part of the £3 million Men’s Health Community Fund (MHCF), a landmark partnership with the Department of Health and Social Care and People’s Health Trust. The deadline for this Expression of Interest is 15 July 2026.
About Movember
Movember is a global charity dedicated to men’s health, funding programmes in mental health, suicide prevention, and physical health. Through this fund, Movember is supporting preventative, community-led approaches that help young men build connection, improve wellbeing, and seek support earlier.
What the Fund Supports
Movember’s £3 million funding stream supports community-based initiatives in non-clinical settings for young men aged 16–35. Programmes must focus on:
- Enabling young men to express health concerns and seek support proactively
- Centring social connection as part of the approach
- Improving self-reported mental health and wellbeing
- Generating practical learning on community-based engagement
How Much Funding Is Available
Grants of £150,000–£300,000 are available for up to three years of project delivery. Movember will support up to 15 grants from this £3 million pot. Multiple applications from the same organisation are permitted.
Who Is Eligible
VCSE organisations in England with a proven track record of working specifically with men and boys. Eligible organisations include registered charities, CICs, and companies limited by guarantee. Key eligibility criteria:
- Delivering projects in England, established for at least three months
- At least one previous project specifically for men/boys with evidence of outcomes
- Targeting young men aged 16–35 in underserved populations (population or place-based inequity)
- Minimum three unrelated trustees/directors aged over 18
How to Apply
Applications must be submitted via the Foundant Grants Management System. Complete the eligibility screening, then submit your Phase 1 Expression of Interest document.
- Information Webinar: 29 June 2026 at 2:00 PM BST
- Phase 1 EOI Deadline: 15 July 2026 at 5:00 PM BST
- Phase 1 Outcome: 27–28 July 2026
- Phase 2 Deadline: 31 August 2026
- Final Decisions: Week of 27 October 2026
